Zurcher Kantonalbank (Zurich Cantonalbank) - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$118,000
-9.9%
4,931
-45.0%
0.00%0.0%
Q4 2020$131,000
+50.6%
8,967
+47.0%
0.00%0.0%
Q3 2020$87,000
-3.3%
6,1020.0%0.00%0.0%
Q2 2020$90,000
+500.0%
6,102
+69.6%
0.00%
Q1 2020$15,000
-11.8%
3,5980.0%0.00%
Q4 2019$17,000
-22.7%
3,5980.0%0.00%
Q3 2019$22,000
-4.3%
3,5980.0%0.00%
Q2 2019$23,000
-11.5%
3,5980.0%0.00%
Q1 2019$26,000
+52.9%
3,5980.0%0.00%
Q4 2018$17,000
-34.6%
3,5980.0%0.00%
Q3 2018$26,000
+225.0%
3,598
+192.3%
0.00%
Q2 2018$8,000
+14.3%
1,2310.0%0.00%
Q1 2018$7,000
+40.0%
1,2310.0%0.00%
Q4 2017$5,000
-58.3%
1,2310.0%0.00%
Q3 2017$12,000
-20.0%
1,2310.0%0.00%
Q2 2017$15,000
-6.2%
1,2310.0%0.00%
Q1 2017$16,000
+6.7%
1,2310.0%0.00%
Q4 2016$15,0000.0%1,2310.0%0.00%
Q3 2016$15,000
+36.4%
1,2310.0%0.00%
Q2 2016$11,000
+83.3%
1,2310.0%0.00%
Q1 2016$6,000
-40.0%
1,2310.0%0.00%
Q4 2015$10,0000.0%1,2310.0%0.00%
Q3 2015$10,0001,2310.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders